Back to Search
NARAE LEE, PHARMD
PHARMD
Pharmacist
NPI: 1851951248Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
PMID 19203843·Int J Radiat Oncol Biol Phys·2009
8-other
Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225.
PMID 19564532·J Clin Oncol·2009
3-trial
Treatment outcomes for patients with synovial sarcoma of the head and neck.
PMID 18366285·Expert Rev Anticancer Ther·2008
4-observational
New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.
PMID 18544439·Semin Oncol·2008
6-review
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.
PMID 17869020·Int J Radiat Oncol Biol Phys·2008
8-other
Reciprocal regulation of bone and energy metabolism.
PMID 18407515·Trends Endocrinol Metab·2008
6-review
Choosing an intensity-modulated radiation therapy technique in the treatment of head-and-neck cancer.
PMID 17241750·Int J Radiat Oncol Biol Phys·2007
8-other
Intensity-modulated radiation therapy in the treatment of head and neck cancer involving the base of the skull.
PMID 17848292·Int J Radiat Oncol Biol Phys·2007
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1121 BOSTON POST RD
RYE, NY 10580 - Phone
- (914) 921-4192
Quick Facts
- NPI
- 1851951248
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile